Cefcapene pivoxil hydrochlorideCAS# 147816-24-8 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 147816-24-8 | SDF | Download SDF |
| PubChem ID | 5282437 | Appearance | Powder |
| Formula | C23H32ClN5O9S2 | M.Wt | 622 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 2,2-dimethylpropanoyloxymethyl (6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)pent-2-enoyl]amino]-3-(carbamoyloxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;hydrate;hydrochloride | ||
| SMILES | CCC=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)OCOC(=O)C(C)(C)C.O.Cl | ||
| Standard InChIKey | LUXIJPQYUCFVAL-XRLCNELCSA-N | ||
| Standard InChI | InChI=1S/C23H29N5O8S2.ClH.H2O/c1-5-6-12(13-9-38-21(24)26-13)16(29)27-14-17(30)28-15(11(7-34-22(25)33)8-37-18(14)28)19(31)35-10-36-20(32)23(2,3)4;;/h6,9,14,18H,5,7-8,10H2,1-4H3,(H2,24,26)(H2,25,33)(H,27,29);1H;1H2/b12-6-;;/t14-,18-;;/m1../s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Cefcapene pivoxil hydrochloride Dilution Calculator
Cefcapene pivoxil hydrochloride Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.6077 mL | 8.0386 mL | 16.0772 mL | 32.1543 mL | 40.1929 mL |
| 5 mM | 0.3215 mL | 1.6077 mL | 3.2154 mL | 6.4309 mL | 8.0386 mL |
| 10 mM | 0.1608 mL | 0.8039 mL | 1.6077 mL | 3.2154 mL | 4.0193 mL |
| 50 mM | 0.0322 mL | 0.1608 mL | 0.3215 mL | 0.6431 mL | 0.8039 mL |
| 100 mM | 0.0161 mL | 0.0804 mL | 0.1608 mL | 0.3215 mL | 0.4019 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Santacruzamate A (CAY10683)
Catalog No.:BCC5488
CAS No.:1477949-42-0
- ω-Conotoxin MVIIC
Catalog No.:BCC5699
CAS No.:147794-23-8
- DCG IV
Catalog No.:BCC5691
CAS No.:147782-19-2
- L-161,982
Catalog No.:BCC7393
CAS No.:147776-06-5
- Repaglinide ethyl ester
Catalog No.:BCC9135
CAS No.:147770-06-7
- Fmoc-O-Phospho-Tyr-OH
Catalog No.:BCC3563
CAS No.:147762-53-6
- 3,4-Dimethoxybenzenepropanamine
Catalog No.:BCN1785
CAS No.:14773-42-3
- 6-O-(3'',4''-Dimethoxycinnamoyl)catalpol
Catalog No.:BCN1655
CAS No.:147714-71-4
- 8-(3-Chlorostyryl)caffeine
Catalog No.:BCC7640
CAS No.:147700-11-6
- WIN 18446
Catalog No.:BCC6273
CAS No.:1477-57-2
- 2-Amino-4-methylbenzothiazole
Catalog No.:BCC8533
CAS No.:1477-42-5
- ZM 226600
Catalog No.:BCC6831
CAS No.:147695-92-9
- Siramesine
Catalog No.:BCC4304
CAS No.:147817-50-3
- Niazimicin
Catalog No.:BCN7641
CAS No.:147821-49-6
- Niazinin
Catalog No.:BCN7623
CAS No.:147821-57-6
- Filic-3-en-25-al
Catalog No.:BCN6445
CAS No.:147850-78-0
- CA-074 Me
Catalog No.:BCC3649
CAS No.:147859-80-1
- Isokadsurenin D
Catalog No.:BCN6615
CAS No.:147976-35-0
- Dinitolmide
Catalog No.:BCC8945
CAS No.:148-01-6
- Beta-Tocopherol
Catalog No.:BCN6683
CAS No.:148-03-8
- Pilocarpin Nitrate
Catalog No.:BCC8234
CAS No.:148-72-1
- Thiabendazole
Catalog No.:BCC3868
CAS No.:148-79-8
- Melphalan
Catalog No.:BCC2403
CAS No.:148-82-3
- Doripenem
Catalog No.:BCC4094
CAS No.:148016-81-3
The pathogenetic role of rod-shaped bacteria containing intracellular granules in the vellus hairs of a patient with perioral dermatitis: A comparison with perioral corticosteroid-induced rosacea.[Pubmed:25894304]
Australas J Dermatol. 2016 Aug;57(3):225-8.
The cause of perioral dermatitis is still unknown. We previously reported that rod-shaped bacteria (RB) containing intracellular granules were detected in cases of perioral dermatitis at a high incidence. The aim of this study was to study further the role of RB in perioral dermatitis. Altogether 10 patients with perioral dermatitis and eight patients with perioral corticosteroid-induced rosacea, who were referred to our department from 2009 to 2014, were examined for the presence of RB, using the tape-stripping toluidine blue method. RB were detected on the surfaces of the roots of vellus hairs from lesions in nine of the 10 patients with perioral dermatitis. In contrast, RB were not detected in any of the eight patients with perioral corticosteroid-induced rosacea. No RB were found in the perioral areas of other types of facial dermatitis, including atopic dermatitis and seboerrheic dermatitis or in 16 healthy controls. We treated four of the patients with perioral dermatitis with minocycline hydrochloride and five with Cefcapene pivoxil hydrochloride hydrate. Three of the patients with perioral dermatitis who were treated with minocycline hydrochloride were cured in 3 to 8 weeks, while the five patients treated with Cefcapene pivoxil hydrochloride hydrate were cured in 2 to 9 weeks. These results strongly suggest that RB (possible fusobacteria) play an important role in perioral dermatitis and that this is probably a distinct clinical entity from corticosteroid-induced rosacea. Cefcapene pivoxil hydrochloride hydrate seems to be an effective treatment for perioral dermatitis associated with RB.
